Paul A. Laviolette - 08 May 2026 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Reporting relationship: Director
Issuer ticker: EW
Reported as of: 08 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 08 May 2026, 21:17:37 UTC
Prior SEC filing: 09 May 2025
Next SEC filing: 11 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Paul A. LaViolette

Key filing fact

Paul A. Laviolette filed Form 4 for Edwards Lifesciences Corp (EW) on 08 May 2026.

Key facts

This page summarizes Paul A. Laviolette's Form 4 filing for Edwards Lifesciences Corp (EW).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 08 May 2026, 21:17.

Change

Previous filing in this sequence was filed on 09 May 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001191249 Primary reporting owner

LAVIOLETTE PAUL A

Relationship: Director
Address: ONE EDWARDS WAY, IRVINE
Signature: /s/ Paul A. LaViolette
Signature date: 08 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EW transaction

Common Stock

Award

Transaction value
Shares: +3,251
Change %: +23%
Price: $0.000000^*
Shares after: 17,552
Date: 08 May 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These restricted stock units were granted on May 8, 2026 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program. They are scheduled to become 100% vested after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders.

SEC remarks

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.